Results 331 to 340 of about 2,975,301 (351)
Some of the next articles are maybe not open access.
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
Nature Reviews Clinical Oncology, 2015Rinath M Jeselsohn +2 more
exaly
Lipid-induced insulin resistance: unravelling the mechanism
Lancet, The, 2010Varman T Samuel, Gerald I Shulman
exaly
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
Nature Reviews Cancer, 2013Michael Holzel +2 more
exaly
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Nature Reviews Clinical Oncology, 2010Deric L Wheeler, Paul M Harari
exaly
Targeting multidrug resistance in cancer
Nature Reviews Drug Discovery, 2006Gergely Szakacs, Michael M Gottesman
exaly
Poised epigenetic states and acquired drug resistance in cancer
Nature Reviews Cancer, 2014Robert Brown, Edward Curry, Luca Magnani
exaly
Bacterial gene amplification: implications for the evolution of antibiotic resistance
Nature Reviews Microbiology, 2009Linus Sandegren, Dan Andersson
exaly